Revenue from operations increased to Rs 7,567 crore in the June quarter as against Rs 6,851 crore in the year-ago period, the drug maker said in a statement.
Dixon Technologies shares tumble 6% in 2 weeks. Is long-term bullishness intact?
The Dixon Technologies stock rebounded from its support near Rs 15,953, with resistance around Rs 17,295. It trades below its 20-day and 50-day EMAs of